From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

ASTCT: CAR-T Toxicity Grading and Management

American Cancer Society Patient Lodging Programs

CancerCare

ASH OnDemand: CAR T-Cell Therapy Consults—Navigating a New Landscape

International Myeloma Foundation: CAR-T Cell Therapy

The EBMT/EHA CAR-T Cell Handbook

Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy

CAR T Patient and Caregiver Guide

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Lymphoma Research Foundation: Treatment Options: CAR T-Cell Therapy

Leukemia and Lymphoma Society: CAR T-Cell Therapy

ASTCT 2022 National Fludarabine Shortage for HCT and CAR T-Cell Recipients: Frequently Asked Questions

American Cancer Society: CAR T-Cell Therapy and its Side Effects

NCCN: Immunotherapy Side Effects - CAR T-Cell Therapy

Practical Guidance for the Diagnosis and Management of Secondary Hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline

ASH-ASTCT COVID-19 Vaccination for HCT and CAR T Cell Recipients: Frequently Asked Questions

BMT infonet: CAR T-Cell therapy

ASTCT NucleusPlus: Insights on Emerging CAR-T Therapies

Prophylactic Tocilizumab in Selected High-Risk or Outpatient CAR-T Populations

Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy in a Patient With Multiple Myeloma

Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy

Fast Facts #12: BCMA Targets